A counterfeit Novo Nordisk A/S Ozempic pen arranged at a warehouse operated by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) in London, UK, on Monday, Feb. 27, 2024. The UK ...
(Reuters) - Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a small trial, researchers reported on Wednesday. The 48 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback